Moussa Diabaté: Everything you need to know

Moussa Diabaté

#14 C

Charlotte Hornets

Status

ACTIVE

STATS

Career Averages

PTS

REB

AST

BLK

STL

6.0

6.5

1.2

0.7

0.6

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2025-26	73	47	26.0	7.9	8.7	1.9	1.0	0.8	1.0	20	0.0	50.0%	3.1	4.9	63.2%	3.1	5.0	63.1%	1.6	2.4	65.9%	3.7	5.0	2.4	1.9	+345	65.3%
2024-25	71	8	17.5	5.7	6.2	0.8	0.6	0.6	0.9	7	0.1	0.0%	2.4	3.9	60.9%	2.4	3.9	59.6%	1.0	1.6	59.5%	2.6	3.5	1.5	0.9	-123	60.9%
2023-24	11	0	5.8	2.6	2.2	0.4	0.1	0.5	0.2	0	0.0	0.0%	0.9	1.7	52.6%	0.9	1.7	52.6%	0.8	1.3	64.3%	1.4	0.8	0.4	2.0	-2	57.6%
2022-23	22	1	8.9	2.7	2.3	0.2	0.4	0.3	0.4	0	0.1	50.0%	1.0	2.0	51.1%	1.1	2.1	51.1%	0.5	0.7	62.5%	1.4	0.9	0.7	0.4	-22	54.6%
Career	177	56	19.2	6.0	6.5	1.2	0.7	0.6	0.8	27	0.1	20.0%	2.4	3.9	61.2%	2.4	4.0	60.6%	1.2	1.8	63.4%	2.9	3.6	1.7	1.4	+198	62.7%

Preseason
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
10/17	NYK	L 113-108	22	11	5	1	1	3	1	0	0	0.0%	4	3	75.0%	4	3	75.0%	6	5	83.3%	1	4	1.0	-6	1	21	82.8%
10/15	MEM	W 145-116	24	18	13	0	1	0	1	0	0	0.0%	7	6	85.7%	7	6	85.7%	8	6	75.0%	9	4	0.0	+3	0	34	85.6%
10/11	DAL	W 120-116	11	6	2	1	0	0	0	0	0	0.0%	4	2	50.0%	4	2	50.0%	6	2	33.3%	1	1	0.0	-11	0	7	45.2%
10/9	OKC	L 122-116	25	14	7	2	0	2	2	0	0	0.0%	9	5	55.6%	9	5	55.6%	7	4	57.1%	2	5	1.0	+14	6	11	57.9%
10/5	OKC	L 135-114	12	7	4	0	1	2	0	0	0	0.0%	5	3	60.0%	5	3	60.0%	3	1	33.3%	2	2	0.0	-4	1	11	55.4%
Preseason Totals			19.5	11.2	6.2	0.8	0.6	1.4	0.8	0.0	0.0	0.0%	5.8	3.8	65.5%	5.8	3.8	65.5%	6.0	3.6	60.0%	3.0	3.2	1.0	-4	1.6	19.0	66.4%

Regular Season
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
4/10	DET	L 118-100	24	8	6	2	2	0	1	0	0	0.0%	4	3	75.0%	4	3	75.0%	4	2	50.0%	2	4	2.0	-7	4	15	69.4%
4/7	BOS	L 113-102	32	2	5	5	0	1	2	0	0	0.0%	3	1	33.3%	3	1	33.3%	0	0	0.0%	3	2	2.5	-18	2	8	33.3%
4/5	MIN	W 122-108	24	8	9	4	1	1	1	0	0	0.0%	4	3	75.0%	4	3	75.0%	2	2	100.0%	3	6	4.0	+9	5	17	82.0%
4/2	PHX	W 127-107	24	4	10	1	0	1	1	0	0	0.0%	2	2	100.0%	2	2	100.0%	0	0	0.0%	3	7	1.0	+10	3	14	100.0%
3/31	BKN	W 117-86	27	10	12	1	0	0	2	0	0	0.0%	6	4	66.7%	6	4	66.7%	2	2	100.0%	6	6	0.5	+25	3	18	72.7%
3/29	BOS	L 114-99	24	4	6	0	0	0	0	0	0	0.0%	2	2	100.0%	2	2	100.0%	2	0	0.0%	2	4	0.0	-17	1	8	69.4%
3/28	PHI	L 118-114	24	10	11	2	0	1	1	0	0	0.0%	7	4	57.1%	7	4	57.1%	3	2	66.7%	7	4	2.0	-7	4	17	60.1%
3/26	NYK	W 114-103	30	2	5	3	1	4	1	0	0	0.0%	2	1	50.0%	2	1	50.0%	2	0	0.0%	2	3	3.0	+15	1	12	34.7%
3/24	SAC	W 134-90	24	17	11	2	2	1	1	0	0	0.0%	7	6	85.7%	7	6	85.7%	7	5	71.4%	5	6	2.0	+26	0	33	84.3%
3/21	MEM	W 124-101	32	11	14	3	2	1	3	0	0	0.0%	6	5	83.3%	6	5	83.3%	2	1	50.0%	6	8	1.0	+21	1	28	79.9%
3/19	ORL	W 130-111	24	3	5	1	1	0	3	0	0	0.0%	3	1	33.3%	3	1	33.3%	1	1	100.0%	1	4	0.3	+10	2	8	43.6%
3/17	MIA	W 136-106	31	8	13	4	1	2	2	0	0	0.0%	6	4	66.7%	6	4	66.7%	0	0	0.0%	5	8	2.0	+21	3	22	66.7%
3/14	SAS	L 115-102	21	4	5	3	0	0	1	0	0	0.0%	7	2	28.6%	7	2	28.6%	0	0	0.0%	2	3	3.0	-13	2	2	28.6%
3/11	SAC	W 117-109	33	2	10	2	0	1	0	0	0	0.0%	3	1	33.3%	3	1	33.3%	0	0	0.0%	6	4	0.0	+15	1	12	33.3%
3/10	POR	W 103-101	30	7	9	4	1	3	1	0	0	0.0%	8	3	37.5%	8	3	37.5%	2	1	50.0%	6	3	4.0	+1	3	14	39.4%
3/8	PHX	L 111-99	26	2	4	2	4	0	2	0	0	0.0%	4	1	25.0%	4	1	25.0%	0	0	0.0%	2	2	1.0	+5	2	6	25.0%
3/6	MIA	L 128-120	31	6	14	1	2	0	0	0	0	0.0%	6	3	50.0%	6	3	50.0%	0	0	0.0%	5	9	0.0	-1	2	19	50.0%
3/4	BOS	W 118-89	29	9	9	6	0	2	0	0	0	0.0%	4	2	50.0%	4	2	50.0%	6	5	83.3%	4	5	0.0	+11	5	23	67.8%
3/3	DAL	W 117-90	22	7	8	0	1	0	2	0	0	0.0%	4	3	75.0%	4	3	75.0%	1	1	100.0%	5	3	0.0	+10	4	12	78.8%
2/28	POR	W 109-93	33	13	11	5	0	0	1	0	0	0.0%	7	5	71.4%	7	5	71.4%	4	3	75.0%	3	8	5.0	+24	2	24	74.2%
2/26	IND	W 133-109	29	14	11	4	0	2	2	0	0	0.0%	8	7	87.5%	8	7	87.5%	0	0	0.0%	5	6	2.0	+18	3	26	87.5%
2/24	CHI	W 131-99	30	9	7	5	3	3	0	0	0	0.0%	4	4	100.0%	4	4	100.0%	2	1	50.0%	3	4	0.0	+22	1	28	92.2%
2/9	DET	L 110-104	18	0	6	0	0	0	2	0	0	0.0%	1	0	0.0%	1	0	0.0%	0	0	0.0%	2	4	0.0	-13	1	0	0.0%
2/7	ATL	W 126-119	32	11	15	2	0	0	0	1	0	0.0%	7	4	57.1%	8	4	50.0%	3	3	100.0%	5	10	0.0	+2	0	24	59.0%
2/5	HOU	W 109-99	29	7	12	4	1	0	1	0	0	0.0%	5	3	60.0%	5	3	60.0%	2	1	50.0%	7	5	4.0	+14	1	20	59.5%
2/2	NOP	W 102-95	28	2	9	2	0	0	0	0	0	0.0%	2	1	50.0%	2	1	50.0%	0	0	0.0%	2	7	0.0	+2	1	13	50.0%
1/31	SAS	W 111-106	33	12	10	6	2	0	0	0	0	0.0%	9	6	66.7%	9	6	66.7%	0	0	0.0%	4	6	0.0	+19	3	25	66.7%
1/29	DAL	W 123-121	32	10	5	3	2	0	0	0	0	0.0%	9	5	55.6%	9	5	55.6%	0	0	0.0%	1	4	0.0	+0	4	11	55.6%
1/28	MEM	W 112-97	33	18	19	2	1	2	3	1	1	100.0%	8	7	87.5%	9	8	88.9%	2	1	50.0%	7	12	0.7	+30	1	37	91.1%
1/26	PHI	W 130-93	20	12	5	0	0	0	1	0	0	0.0%	7	6	85.7%	7	6	85.7%	1	0	0.0%	2	3	0.0	+32	1	15	80.6%
1/24	WAS	W 119-115	32	11	14	0	0	1	2	0	0	0.0%	3	2	66.7%	3	2	66.7%	8	7	87.5%	5	9	0.0	+13	0	25	84.4%
1/22	ORL	W 124-97	16	10	4	1	1	0	1	0	0	0.0%	4	4	100.0%	4	4	100.0%	3	2	66.7%	2	2	1.0	+12	5	14	94.0%
1/21	CLE	L 94-87	29	4	5	0	3	1	2	0	0	0.0%	1	1	100.0%	1	1	100.0%	6	2	33.3%	3	2	0.0	+1	4	7	54.9%
1/18	DEN	W 110-87	24	4	9	2	1	0	0	0	0	0.0%	6	2	33.3%	6	2	33.3%	0	0	0.0%	2	7	0.0	+6	3	9	33.3%
1/15	LAL	W 135-117	30	8	6	2	0	0	3	0	0	0.0%	5	4	80.0%	5	4	80.0%	0	0	0.0%	3	3	0.7	+9	3	11	80.0%
1/12	LAC	L 117-109	35	13	15	4	4	1	1	0	0	0.0%	10	6	60.0%	10	6	60.0%	2	1	50.0%	5	10	4.0	-4	3	30	59.7%
1/10	UTA	W 150-95	24	10	10	1	2	0	1	0	0	0.0%	3	3	100.0%	3	3	100.0%	7	4	57.1%	5	5	1.0	+38	2	25	82.2%
1/8	IND	L 114-112	35	10	5	1	1	0	1	0	0	0.0%	5	2	40.0%	5	2	40.0%	8	6	75.0%	2	3	1.0	-3	4	10	58.7%
1/7	TOR	L 97-96	30	6	11	1	2	2	2	0	0	0.0%	4	2	50.0%	4	2	50.0%	2	2	100.0%	2	9	0.5	+0	1	18	61.5%
1/5	OKC	W 124-97	28	9	12	5	0	0	0	0	0	0.0%	5	4	80.0%	5	4	80.0%	2	1	50.0%	6	6	0.0	+21	0	24	76.5%
12/31	GSW	L 132-125	27	0	8	3	1	1	2	0	0	0.0%	3	0	0.0%	3	0	0.0%	0	0	0.0%	2	6	1.5	-8	4	4	0.0%
12/29	MIL	L 123-113	34	14	9	3	1	2	2	0	0	0.0%	9	6	66.7%	9	6	66.7%	2	2	100.0%	6	3	1.5	-12	4	21	70.9%
12/26	ORL	W 120-105	32	10	12	3	1	0	0	0	0	0.0%	4	3	75.0%	4	3	75.0%	8	4	50.0%	6	6	0.0	+6	3	26	66.5%
12/23	WAS	W 126-109	35	12	18	1	0	0	0	0	0	0.0%	6	6	100.0%	6	6	100.0%	0	0	0.0%	8	10	0.0	+38	2	29	100.0%
12/22	CLE	L 139-132	28	5	14	2	0	6	3	0	0	0.0%	6	2	33.3%	6	2	33.3%	2	1	50.0%	6	8	0.7	+8	4	18	36.3%
12/20	DET	L 112-86	16	1	3	0	0	1	0	0	0	0.0%	2	0	0.0%	2	0	0.0%	2	1	50.0%	0	3	0.0	-1	1	4	17.4%
12/18	ATL	W 133-126	17	5	6	2	0	0	0	0	0	0.0%	4	2	50.0%	4	2	50.0%	4	1	25.0%	1	5	0.0	+9	1	9	43.4%
12/14	CLE	W 119-111	21	5	6	0	1	1	1	0	0	0.0%	3	2	66.7%	3	2	66.7%	1	1	100.0%	2	4	0.0	-6	5	8	72.7%
12/12	CHI	L 129-126	12	2	3	0	1	0	0	0	0	0.0%	2	1	50.0%	2	1	50.0%	0	0	0.0%	2	1	0.0	-17	3	2	50.0%
12/5	TOR	W 111-86	15	3	4	1	0	0	1	0	0	0.0%	2	1	50.0%	2	1	50.0%	2	1	50.0%	2	2	1.0	+7	0	7	52.1%
12/3	NYK	L 119-104	19	2	8	2	0	1	2	0	0	0.0%	2	1	50.0%	2	1	50.0%	0	0	0.0%	3	5	1.0	-6	4	8	50.0%
12/1	BKN	L 116-103	22	10	6	1	1	2	0	0	0	0.0%	9	5	55.6%	9	5	55.6%	0	0	0.0%	2	4	0.0	-4	3	15	55.6%
11/29	TOR	W 118-111	30	7	9	2	0	1	0	0	0	0.0%	5	3	60.0%	5	3	60.0%	2	1	50.0%	4	5	0.0	+19	4	13	59.5%
11/28	CHI	W 123-116	18	4	8	2	0	2	1	0	0	0.0%	3	1	33.3%	3	1	33.3%	2	2	100.0%	3	5	2.0	+29	2	13	51.5%
11/26	NYK	L 129-101	15	4	4	0	2	0	1	0	0	0.0%	2	2	100.0%	2	2	100.0%	0	0	0.0%	1	3	0.0	-4	4	7	100.0%
11/23	ATL	L 113-110	25	12	11	1	0	0	1	0	0	0.0%	4	4	100.0%	4	4	100.0%	4	4	100.0%	5	6	1.0	-13	0	25	104.2%
11/22	LAC	L 131-116	24	6	7	1	0	0	0	0	0	0.0%	4	2	50.0%	4	2	50.0%	4	2	50.0%	3	4	0.0	-12	3	10	52.1%
11/19	IND	L 127-118	24	8	12	3	0	0	1	0	0	0.0%	9	3	33.3%	9	3	33.3%	3	2	66.7%	7	5	3.0	+2	3	13	38.8%
11/17	TOR	L 110-108	19	8	7	2	4	0	1	0	0	0.0%	3	3	100.0%	3	3	100.0%	3	2	66.7%	2	5	2.0	+9	1	21	92.6%
11/15	OKC	L 109-96	23	13	11	4	1	1	2	0	0	0.0%	7	6	85.7%	7	6	85.7%	1	1	100.0%	4	7	2.0	-2	2	27	87.4%
11/14	MIL	L 147-134	43	15	11	1	0	1	1	0	0	0.0%	8	5	62.5%	8	5	62.5%	6	5	83.3%	6	5	1.0	-16	6	22	70.5%
11/12	MIL	W 111-100	23	7	13	2	1	1	1	0	0	0.0%	3	1	33.3%	3	1	33.3%	6	5	83.3%	8	5	2.0	-8	2	21	62.1%
11/10	LAL	L 121-111	28	8	3	1	3	2	0	0	0	0.0%	4	4	100.0%	4	4	100.0%	0	0	0.0%	1	2	0.0	+0	2	17	100.0%
11/7	MIA	L 126-108	21	10	11	0	3	0	1	0	0	0.0%	6	4	66.7%	6	4	66.7%	5	2	40.0%	7	4	0.0	-17	2	19	61.0%
11/4	NOP	L 116-112	17	6	5	2	1	2	1	0	0	0.0%	3	2	66.7%	3	2	66.7%	4	2	50.0%	3	2	2.0	-12	3	11	63.0%
11/2	UTA	W 126-103	22	17	12	0	1	0	0	0	0	0.0%	9	7	77.8%	9	7	77.8%	3	3	100.0%	6	6	0.0	-1	3	30	82.4%
11/1	MIN	L 122-105	18	11	9	1	0	0	0	0	0	0.0%	5	3	60.0%	5	3	60.0%	6	5	83.3%	5	4	0.0	+5	2	20	72.0%
10/30	ORL	L 123-107	20	10	6	1	2	0	0	0	0	0.0%	8	4	50.0%	8	4	50.0%	2	2	100.0%	4	2	0.0	-1	2	13	56.3%
10/28	MIA	L 144-117	19	8	2	0	1	0	1	0	0	0.0%	4	3	75.0%	4	3	75.0%	2	2	100.0%	1	1	0.0	-22	3	7	82.0%
10/26	WAS	W 139-113	22	12	10	1	2	0	1	0	0	0.0%	9	4	44.4%	9	4	44.4%	5	4	80.0%	4	6	1.0	+12	1	21	53.6%
10/25	PHI	L 125-121	16	6	2	0	1	1	0	0	0	0.0%	2	2	100.0%	2	2	100.0%	7	2	28.6%	0	2	0.0	-4	2	9	59.1%
10/22	BKN	W 136-117	21	13	9	0	1	1	2	0	0	0.0%	7	5	71.4%	7	5	71.4%	4	3	75.0%	4	5	0.0	+8	3	18	74.2%
Regular Season Totals			26.0	7.9	8.7	1.9	1.0	0.8	1.0	0.0	0.0	50.0%	5.0	3.1	63.1%	5.0	3.2	63.1%	2.4	1.6	65.9%	3.7	5.0	1.9	+345	2.4	19.3	65.3%

Moussa Diabaté: Breaking News

Diabate had two points (1-4 FG), eight rebounds, two assists and three blocks across 18 minutes during Friday's 121-90 Play-In Game loss to the Magic. Diabate tallied at least three blocks for the seventh time this season, closing out what could be considered a breakout campaign. However, although he was able to establish himself as the starting center in Charlotte, there are certainly some questions when it comes to his overall impact, especially for a team with lofty ambitions. In 75 appearances, Diabate averaged 7.8 points, 8.8 rebounds and 1.7 combined steals and blocks.

Diabate (hip) is available for Friday's Play-In Tournament game versus the Magic. Diabate should continue to start Friday, and with him active, there will be fewer minutes available for Ryan Kalkbrenner and Xavier Tillman. In Tuesday's Play-In Tournament win over Miami, Diabate finished with eight points, 14 rebounds, one assist and one block over 36 minutes.

Diabate is questionable for Friday's Play-In Tournament game against the Magic due to left hip soreness. It's not clear as to when Diabate picked up this injury, as he logged 36 minutes during Tuesday's overtime win over the Heat. The team will presumably monitor the injury closely leading up to tipoff and should have more information to share on his availability closer to game time.